Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Taniguchi

Showing results (881-890 of 922) with videos related to

Pageof 93
Sort By:
Journal of Clinical Pharmacy and Therapeutics|September 9, 2006
2'-,5'-Oligoadenylate synthetase response ratio predicting virological response to PEG-interferon-alpha2b plus ribavirin therapy in patients with chronic hepatitis CK-I Kim, S-R Kim, N Sasase, et al.
Cancer Research|May 3, 2019
Selective EGLN Inhibition Enables Ablative Radiotherapy and Improves Survival in Unresectable Pancreatic CancerTara N Fujimoto, Lauren E Colbert, Yanqing Huang, et al.
Cancer Medicine|August 29, 2018
Dose escalation of radiotherapy in unresectable extrahepatic cholangiocarcinomaDalia Elganainy, Emma B Holliday, Cullen M Taniguchi, et al.
International Journal of Radiation Oncology, Biology, Physics|May 19, 2022
Patient-Reported Bowel and Urinary Function in Long-Term Survivors of Squamous Cell Carcinoma of the Anus Treated With Definitive Intensity Modulated Radiation Therapy And Concurrent ChemotherapyBrian De, Kelsey L Corrigan, Michael K Rooney, et al.
Clinical and Translational Radiation Oncology|March 5, 2021
Implementation of a stereotactic body radiotherapy program for unresectable pancreatic cancer in an integrated community academic radiation oncology satellite networkAlexander Augustyn, Valerie I Reed, Neelofur Ahmad, et al.
Nature Medicine|September 5, 2001
Activation of natural killer T cells by alpha-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetesS Sharif, G A Arreaza, P Zucker, et al.
Scientific Reports|February 15, 2019
Enteral Activation of WR-2721 Mediates Radioprotection and Improved Survival from Lethal Fractionated RadiationJessica M Molkentine, Tara N Fujimoto, Thomas D Horvath, et al.
Physical Review Letters|May 16, 2007
High-energy scale revival and giant kink in the dispersion of a cuprate superconductorB P Xie, K Yang, D W Shen, et al.
Cancer|April 13, 2022
Ablative liver radiotherapy for unresected intrahepatic cholangiocarcinoma: Patterns of care and survival in the United StatesBrian De, Hop S Tran Cao, Jean-Nicolas Vauthey, et al.
Advances in Radiation Oncology|December 22, 2021
Stereotactic Versus Conventional Radiation Therapy for Patients With Pancreatic Cancer in the Modern EraJoseph Abi Jaoude, Connor P Thunshelle, Ramez Kouzy, et al.
Pageof 93

Showing results (881-890 of 922) with videos related to

Sort By:
Pageof 93
Journal of Clinical Pharmacy and Therapeutics|September 9, 2006
2'-,5'-Oligoadenylate synthetase response ratio predicting virological response to PEG-interferon-alpha2b plus ribavirin therapy in patients with chronic hepatitis CK-I Kim, S-R Kim, N Sasase, et al.
Cancer Research|May 3, 2019
Selective EGLN Inhibition Enables Ablative Radiotherapy and Improves Survival in Unresectable Pancreatic CancerTara N Fujimoto, Lauren E Colbert, Yanqing Huang, et al.
Cancer Medicine|August 29, 2018
Dose escalation of radiotherapy in unresectable extrahepatic cholangiocarcinomaDalia Elganainy, Emma B Holliday, Cullen M Taniguchi, et al.
International Journal of Radiation Oncology, Biology, Physics|May 19, 2022
Patient-Reported Bowel and Urinary Function in Long-Term Survivors of Squamous Cell Carcinoma of the Anus Treated With Definitive Intensity Modulated Radiation Therapy And Concurrent ChemotherapyBrian De, Kelsey L Corrigan, Michael K Rooney, et al.
Clinical and Translational Radiation Oncology|March 5, 2021
Implementation of a stereotactic body radiotherapy program for unresectable pancreatic cancer in an integrated community academic radiation oncology satellite networkAlexander Augustyn, Valerie I Reed, Neelofur Ahmad, et al.
Nature Medicine|September 5, 2001
Activation of natural killer T cells by alpha-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetesS Sharif, G A Arreaza, P Zucker, et al.
Scientific Reports|February 15, 2019
Enteral Activation of WR-2721 Mediates Radioprotection and Improved Survival from Lethal Fractionated RadiationJessica M Molkentine, Tara N Fujimoto, Thomas D Horvath, et al.
Physical Review Letters|May 16, 2007
High-energy scale revival and giant kink in the dispersion of a cuprate superconductorB P Xie, K Yang, D W Shen, et al.
Cancer|April 13, 2022
Ablative liver radiotherapy for unresected intrahepatic cholangiocarcinoma: Patterns of care and survival in the United StatesBrian De, Hop S Tran Cao, Jean-Nicolas Vauthey, et al.
Advances in Radiation Oncology|December 22, 2021
Stereotactic Versus Conventional Radiation Therapy for Patients With Pancreatic Cancer in the Modern EraJoseph Abi Jaoude, Connor P Thunshelle, Ramez Kouzy, et al.
Pageof 93